Please use this identifier to cite or link to this item:
|Title:||Clinical trials in Southeast Asia: An update|
|Citation:||Wong, E. (2009). Clinical trials in Southeast Asia: An update. Drug Information Journal 43 (1) : 57-61. ScholarBank@NUS Repository.|
|Abstract:||In recent years, the environment and infrastructure available for conducting clinical trials in Southeast Asia have improved. The region has attracted an increasing number of drug development trials from US and European sponsors. Lately, some Japanese pharmaceutical companies have begun to conduct Pan-Asian multicenter trials involving some Southeast Asian countries. It is expected that the globalization movement in drug development and the emerging trend of Pan-Asian trials will create increasing demands on Southeast Asian sites and fuel the growth of the clinical trial market in the region. Copyright © 2009 Drug Information Association, Inc.|
|Source Title:||Drug Information Journal|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Oct 12, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.